Clarigard 250mg 10 Tablets

Babies: Not applicable Lactating mothers: Clarigard is safe to use in lactating mothers. It is not excreted in breast milk.
Seek a doctor’s advice before taking this medicine. Pregnancy: Clarigard is not safe during pregnancy. There are limited and inadequate studies on the use of clarigard in pregnant women.
Seek a doctor’s advice before taking this medicine. Driving: Clarigard may cause blurred vision, decreased alertness, make you feel sleepy and dizzy. Do not drive if these symptoms occur. Alcohol: Consuming alcohol along with clarigard does not cause harmful side effects. Kidney: Clarigard should be used with caution in patients with kidney problems.
You may need dosage adjustment. Seek a doctor’s advice before taking this medicine.
Liver: Clarigard is safe to use in patients with liver disease. Seek a doctor’s advice before taking this medicine..

Abnormal taste Nausea Vomiting Diarrhoea Abdominal pain Rashes Heartburn Headache.

Clarigard prevents protein synthesis in bacteria, thereby decreasing the growth of the bacteria and prevent infection..

If you miss a dose, take it as soon as possible. If it is near the time of the next dose, then skip the missed dose.
Take the prescribed dose on your regular time daily. Don't double the dose to catch up with the missed dose..

• Clarigard is used to treat various bacterial infections. • Take the medicine exactly as advised by the doctor. Do not miss the dose even if you feel better to prevent antibiotic resistance. • If you experience any undesirable effects, then stop the medicine and seek the doctor’s advice. • Avoid taking antacids 2 hours before and after taking clarigard. • Clarigard can be taken with or without food..

Contraindicated • Clarigard + Cabergoline: Clarigard increases the effect of cabergoline by decreasing the metabolism. • Clarigard + Indapamide: Concurrent administration causes an increase in qtc interval resulting in tachycardia, fits, and sudden death. Serious • Clarigard + Aripiprazole: Concurrent use may increase the level or effect of aripiprazole by decreasing the metabolism. • Clarigard + Atorvastatin: Concurrent use may increase the level or effect of atorvastatin by affecting metabolism and p glycoprotein efflux transporter. • Clarigard + Citalopram: Concurrent administration increase toxicity of others by prolongation of qtc interval leading to ventricular tachycardia. Monitor closely • Clarigard + Bromocriptine: Concurrent use may increase the levels of bromocriptine by decreasing its metabolism. • Clarigard + Dexamethasone: Concurrent use may increase the level or effect of dexamethasone by p-glycoprotein efflux transporter. Minor • Clarigard + Zolpidem: Clarigard increases the level or effect of zolpidem by decreasing the metabolism..